085660.KQ KOE
Chabiotech Co.,Ltd.
1W: +6.3%
1M: +1.2%
3M: -21.7%
YTD: -59.5%
1Y: -21.9%
3Y: -35.4%
5Y: -68.3%
₩8,460.00 ($6.29)
-210.00 (-2.42%)
Weekly Expected Move ±4.6%
₩7685
₩8072
₩8460
₩8848
₩9235
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$72.1B
-45.5% ▼
Capital Expenditures
$147.0B
-49.2% ▼
5Y CAGR: +2.6%
Free Cash Flow
-$219.1B
-48.0% ▼
Dividends Paid
$419M
+67.8% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$2.2B
-98.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14.0B | -$47.5B | -$8.4B | -$14.6B | -$109.9B |
| Depreciation & Amort. | $27.5B | $32.8B | $37.8B | $45.0B | $56.3B |
| Stock-Based Comp. | $482M | $485M | $191M | $257M | $0 |
| Change in Working Capital | -$16.6B | -$15.1B | -$42.4B | -$26.1B | -$54.8B |
| Other Non-Cash Items | $87.0B | $73.2B | $25.8B | -$54.2B | $36.3B |
| Operating Cash Flow | $23.0B | -$22.1B | $13.0B | -$49.5B | -$72.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$115.5B | -$128.9B | -$70.4B | -$93.9B | -$152.1B |
| Acquisitions (Net) | $46.9B | $3.0B | -$2.0B | -$833M | -$40.7B |
| Investment Purchases | -$82.2B | -$185.3B | -$290.7B | -$298.1B | -$165.0B |
| Investment Sales | $124.7B | $235.9B | $285.9B | $350.8B | $232.5B |
| Other Investing | -$38.3B | $663M | -$6.5B | $49.5B | -$15.2B |
| Investing Cash Flow | -$64.4B | -$74.6B | -$83.7B | $7.4B | -$140.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | $41.6B | $61.7B | $36.2B | $262.7B | $67.9B |
| Stock Repurchased | $0 | $0 | -$3.0B | -$53M | $0 |
| Dividends Paid | -$4.0B | -$1.2B | -$1.5B | -$1.3B | -$419M |
| Other Financing | $37.1B | $10.9B | $8.0B | -$91.6B | -$26.2B |
| Financing Cash Flow | $30.2B | $50.4B | $66.4B | $214.0B | $222.9B |
| Net Change in Cash | $1.4B | -$55.9B | -$5.9B | $174.7B | $2.2B |
| Cash End of Period | $122.5B | $66.6B | $60.7B | $235.4B | $237.6B |
| Free Cash Flow | -$92.4B | -$151.0B | -$62.9B | -$148.1B | -$219.1B |